Wenchang Huang

Dr. Wenchang Huang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BSBo Shi
Bo Shi
LSLeiting Shen
Leiting Shen
WHWenchang Huang
Wenchang Huang
LClinghao cai
linghao cai
SYSisi Yang
Sisi Yang
DLDengming Lai
Dengming Lai
Objective: To explore the surgical risk variables in patients with necrotizing enterocolitis (NEC) and develop a nomogram model for predicting the surgical intervention timing of NEC. Methods: Infants diagnosed with NEC were enrolled in our study. We gathered information from clinical data, laboratory examinations, and radiological manifestations. Using LASSO (least absolute shrinkage and selection operator) regression analysis and multivariate logistic regression analysis, a clinical prediction model based on the logistic nomogram was developed. The performance of the nomogram model was evaluated using the receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis (DCA). Results: A surgical intervention risk nomogram based on hypothermia, absent bowel sounds, WBC > 20 × 109/L or < 5 × 109/L, CRP > 50 mg/L, pneumatosis intestinalis, and ascites was practical, had a moderate predictive value (AUC > 0.8), improved calibration, and enhanced clinical benefit. Conclusions: This simple and reliable clinical prediction nomogram model can help physicians evaluate children with NEC in a fast and effective manner, enabling the early identification and diagnosis of children at risk for surgery. It offers clinical revolutionary value for the development of medical or surgical treatment plans for children with NEC.

Verified
Journal Article
Open access
PDF file
YZYijun Zhao
Yijun Zhao
FYFan Yang
Fan Yang
LZLinfeng Zhu
Linfeng Zhu
WHWenchang Huang
Wenchang Huang
XWXiaohao Wang
Xiaohao Wang
GCGuangjie Chen
Guangjie Chen
Objective: This study aimed to evaluate the effectiveness of robot-assisted laparoscopic pyeloplasty (RALP) in pediatric hydronephrosis with or without abdominal pain symptoms, and to compare post-operative outcomes between these two clinical subtypes. Methods: We retrospectively reviewed pediatric patients who underwent RALP at our institution between April 2020 and October 2024. Patients were categorized into hydronephrosis with and without abdominal pain groups. The primary endpoints were renal pelvis anteroposterior diameter (APD) and percent improvement in APD (PI-APD). Inverse probability of treatment weighting (IPTW) was applied to minimize selection bias and balance baseline covariates. Results: A total of 273 pediatric patients were analyzed, including 104 cases with abdominal pain and 169 without. After IPTW adjustment, the baseline characteristics of the groups were comparable. At 6 months post-operative, the abdominal pain group showed slower reduction in APD (1.3 cm vs. 1.2 cm, p < 0.05) and PI-APD (37% vs. 50%, p < 0.05). No significant differences were observed at the 12-month or last follow-up. The overall surgical success rate was 97.1% (265/273). The IPTW-adjusted analysis revealed a higher surgical success rate in the abdominal pain group (99.9% vs. 97.1%, p < 0.05). Conclusions: RALP is safe and effective for pediatric hydronephrosis, regardless of the presence of abdominal pain. Although both groups showed comparable recovery at 12 months or last follow-up, the patients with abdominal pain exhibited slower improvement at 6 months, suggesting potential differences in early post-operative remodeling between these subtypes.